AMZN
Amazon.com, Inc.
AMZN has the edge over PII overall, supported by stronger valuation and stronger modeled upside.
PII
Polaris Inc.
PII's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
PII Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
PII's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
PII PE Valuation
PII has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
PII Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PII, with profitability improving. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over PII on earnings quality, reporting a profit while its opponent remains loss making.
PII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.84 | — |
| Q3 2026 | -$3.69 | -$1.03 |
| Q2 2026 | -$4.63 | -$2.74 |
| Q1 2026 | -$7.84 | -1204% |
| Q4 2025 | -$8.18 | -519% |
| Q3 2025 | -$2.66 | -174% |
| Q2 2025 | -$1.89 | -133% |
| Q1 2025 | $0.71 | -90% |
| Q4 2024 | $1.95 | -78% |
PII lost $3.69 per share over the past year, a bigger loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over PII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over PII on profitability, with a higher operating margin.
PII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +11% |
| Q2 2026 | $2B | +9.2% |
| Q1 2026 | $1.7B | +8% |
| Q4 2025 | $1.9B | +9.5% |
| Q3 2025 | $1.8B | +6.9% |
| Q2 2025 | $1.9B | -5.5% |
| Q1 2025 | $1.5B | -12% |
| Q4 2024 | $1.8B | -23% |
PII's revenue is recovering but still below its 2022 peak: $2B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.6% | +2.5 points |
| Q2 2026 | 7.4% | +8.1 points |
| Q1 2026 | -2.4% | 0 points |
| Q4 2025 | -17% | -20 points |
| Q3 2025 | 1.1% | -2.7 points |
| Q2 2025 | -0.7% | -6.8 points |
| Q1 2025 | -2.4% | -4.6 points |
| Q4 2024 | 3.8% | -2.5 points |
PII's operating margin was 3.6% last quarter, up 2.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
PII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $315.3M | +170% |
| Q2 2026 | $186.1M | -33% |
| Q1 2026 | -$349.9M | -835% |
| Q4 2025 | $114M | -17% |
| Q3 2025 | $116.7M | +$149.1M |
| Q2 2025 | $279.8M | +254% |
| Q1 2025 | $47.6M | +$225.1M |
| Q4 2024 | $137.3M | -69% |
PII has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over PII on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
PII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +200K shares |
| 1 year | +2.8% | +1.6M shares |
| 3 years | +1.2% | +700K shares |
| 5 years | -6.1% | -3.8M shares |
| Available history | -6.1% | -3.8M shares |
PII has 59M diluted shares, up 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $100,000 |
| Q1 2026 | $9.2M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.4M |
| Q4 2024 | $400,000 |
PII spent $9M buying back its own shares over the past year, about three times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over PII on leverage, with a lower net debt burden relative to earnings.
PII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.5x | High |
| Q2 2026 | 21.0x | High |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | 2.4x | Moderate |
PII's net debt is about 10 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
PII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.6 | Neutral |
| Stochastic | 51.1 | Neutral |
PII's weekly RSI is 55 (neutral) and its Stochastic is 51 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
PII PE vs Consumer Cyclical Sector
| Metric | PII | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
PII has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over PII on trend strength, trading above more of its moving averages.
PII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.6 | 14% above |
| 20 week MA | $62.0 | 4.3% above |
| 50 week MA | $63.5 | 2% above |
| 100 week MA | $56.8 | 14% above |
| 200 week MA | $76.1 | 15% below |
PII has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 15% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over PII on returns for 2026, with the stronger performance.
PII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.4 | $98.7 | -2.6% |
| 2021 | $98.7 | $106.3 | +7.6% |
| 2022 | $106.3 | $100.8 | -5.2% |
| 2023 | $100.8 | $94.8 | -6% |
| 2024 | $94.8 | $57.4 | -39% |
| 2025 | $57.4 | $66.3 | +15% |
| 2026 YTD | $66.3 | $64.7 | -2.4% |
PII has finished lower in four of the last six years. It's down 2.4% so far in 2026.